U.S. Markets open in 24 hrs, 33 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,309.92 | -154.48 | -1.48% |
| NASDAQ | 2,138.44 | -37.61 | -1.73% |
| S&P 500 | 1,091.49 | -19.14 | -1.72% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 27.8901 09:30 AM EST | |
|---|---|---|
| Day High | 28.56 11:06 AM EST |
|
| Range | 0.67 |
| Volume | 232,992 | |
|---|---|---|
| 30-Day Avg Vol | 1.16 M |
|
| Difference | -80.02% |
| Market Cap | 1.75 B | |
|---|---|---|
| Mkt Cap Chg | -27.33 M |
| Shares Out | 62.13 M | |
|---|---|---|
| % Shrs Traded | 0.37% | |
| 1yr EPS Est | 0.762 |
| 52-Wk Low | 21.85 | |
|---|---|---|
| 52-Wk High | 37.02 |
|
| Range | 15.17 |
| Prev Close | 28.63 11/25/09 | |
|---|---|---|
| Today's Open | 28.01 | |
| Change | -2.17% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 4.56 M |
| Revenue (LFY) | 194.34 M | |
|---|---|---|
| Earnings (LFY) | 1.95 M | |
| Earnings (MRQ) | 8.23 M | |
| Next Earn Est | 0.20 | |
| Next Earnings | 02/24/2010 |
|
| EPS (TTM) | -0.16 | |
| 1yr EPS Growth | 576.25% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | 36.00 | |
| PEG Ratio | 1.54 | |
| Return on Equity | -10.58 | |
| Beta | 0.66 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Onyx Pharmaceuticals' cancer drug could turn out to be a real gem. Working with health care behemoth Bayer, the biotechnology company developed Nexavar, an FDA-approved treatment for advanced kidney cancer ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.2 2/24/10 | — — |
—
—
|
| Last Quarter | 0.223 9/30/09 | 0.14 9/30/09 |
-0.083
Missed
|
| 2 Quarters Ago | 0.143 6/30/09 | 0.16 6/30/09 |
0.017
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 69.14 M | 194.34 M |
| Gross Profit | -8.58 M | 193.01 M |
| Operating Income | 10.06 M | -10.40 M |
| Net Income | 8.23 M | 1.95 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts